BCL2L12 improves risk stratification and prediction of BFM-chemotherapy response in childhood acute lymphoblastic leukemia
暂无分享,去创建一个
A. Scorilas | M. Avgeris | C. Kontos | M. Baka | D. Doganis | H. Kosmidis | D. Gourgiotis | A. Marmarinos | Despina Piatopoulou | M. Xagorari | L. Stamati | T. Anastasiou